✦ LIBER ✦

Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment

✍ Scribed by Gregory Holmes; Lawrence Galitz; Peter Hu; William Lyness

Book ID: 108641423
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 215 KB
Volume: 60
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2005.02476.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin aspart pharmacokinetics in obesi

Insulin aspart pharmacokinetics in obesity, renal and liver impairment

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Pharmacokinetics of Vandetanib in Subjec

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

✍ Angelika Weil, Dr Paul Martin, Robert Smith, Stuart Oliver, Peter Langmuir, Jess 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 220 KB

Asenapine Pharmacokinetics in Hepatic an

Asenapine Pharmacokinetics in Hepatic and Renal Impairment

✍ Dr Pierre Peeters, Howard Bockbrader, Edwin Spaans, Peter Dogterom, Kenneth Lass 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 192 KB

Pharmacokinetics of topiramate in patien

Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment

✍ Manitpisitkul, Prasarn; Curtin, Christopher R.; Shalayda, Kevin; Wang, Shean-She 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Pharmacokinetics of Intravenous Conivapt

Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment

✍ Michael J. Roy, Keith A. Erdman, Anura T. Abeyratne… 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB

Effect of Renal or Hepatic Impairment on

Effect of Renal or Hepatic Impairment on the Pharmacokinetics of Mirabegron

✍ James Dickinson, Michaelene Lewand, Taiji Sawamoto, Walter Krauwinkel, Marloes S 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 395 KB